Boenning & Scattergood Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UHT
Universal Health Realty Income Trust
UHT
|
+$4.88M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.24M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$1.05M |
| 4 |
Chemours
CC
|
+$930K |
| 5 |
CVS Health
CVS
|
+$928K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanta Services
PWR
|
+$901K |
| 2 |
Cambria Value and Momentum ETF
VAMO
|
+$768K |
| 3 |
PX
Praxair Inc
PX
|
+$753K |
| 4 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$728K |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$676K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.41% |
| 2 | Technology | 12.16% |
| 3 | Miscellaneous | 11.03% |
| 4 | Industrials | 10.01% |
| 5 | Financials | 9.78% |
Similar funds
Boenning & Scattergood's Q4 2018 Portfolio in Review
As of Q4 2018, Boenning & Scattergood held 291 positions worth $287M, down 8.9% from $315M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Boenning & Scattergood deployed $13.8M of net new capital in Q4 2018, opening 20 new positions and adding to 124 existing holdings. Its largest new stake was iShares Biotechnology ETF: 11,674 shares worth $1.13M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Miscellaneous.
On the sell side, the largest reduction was Starbucks, an estimated $660K trimmed.
- Boenning & Scattergood's largest Q4 2018 buy was iShares Biotechnology ETF: 11,674 shares worth $1.13M.
- Boenning & Scattergood added most to Universal Health Realty Income Trust in Q4 2018, an estimated $4.88M increase.
- Boenning & Scattergood's biggest Q4 2018 reduction was Starbucks, cutting an estimated $660K.
- Boenning & Scattergood fully exited Quanta Services in Q4 2018, selling an estimated $901K.
- Boenning & Scattergood's ten largest holdings make up 24% of its $287M portfolio in Q4 2018.
- Boenning & Scattergood opened 20 new positions and closed 29 in Q4 2018.
- Boenning & Scattergood's portfolio value fell 8.9% quarter-over-quarter to $287M.
Based on Boenning & Scattergood's 13F filing for Q4 2018, filed 22 Jan 2019.